(NASDAQ: NEOG) Neogen's forecast annual revenue growth rate of 0.25% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.85%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.4%.
Neogen's revenue in 2026 is $880,319,000.On average, 7 Wall Street analysts forecast NEOG's revenue for 2026 to be $188,821,252,547, with the lowest NEOG revenue forecast at $180,922,884,177, and the highest NEOG revenue forecast at $194,735,783,971. On average, 7 Wall Street analysts forecast NEOG's revenue for 2027 to be $192,599,678,837, with the lowest NEOG revenue forecast at $183,522,319,650, and the highest NEOG revenue forecast at $199,654,046,401.
In 2028, NEOG is forecast to generate $191,690,420,237 in revenue, with the lowest revenue forecast at $182,754,452,937 and the highest revenue forecast at $198,847,025,012.